Teva names Levin CEO

Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) hired Jeremy Levin as president and CEO, effective in May. Levin was SVP of strategy, alliances and transactions at Bristol-Myers Squibb Co. (NYSE:BMY). He succeeds Shlomo Yanai, who is retiring. Teva was up $2.74 to $43.10 on Tuesday. ...